Status:
COMPLETED
Balance of Angiotensin II Receptors in Vessel Function After Preeclampsia
Lead Sponsor:
Anna Stanhewicz, PhD
Conditions:
Preeclampsia
Eligibility:
FEMALE
18-45 years
Phase:
EARLY_PHASE1
Brief Summary
Otherwise healthy women who develop preeclampsia during pregnancy are more likely to develop and die of cardiovascular disease later in life. The reason why this occurs is unclear but may be related t...
Eligibility Criteria
Inclusion
- women who had preeclampsia and women who did not have preeclampsia
- 12 weeks to 5 years postpartum
- 18-45 years old
Exclusion
- history of hypertension or metabolic disease before pregnancy
- history of gestational diabetes or gestational hypertension
- skin diseases
- current tobacco use
- current antihypertensive medication
- statin or other cholesterol-lowering medication
- currently pregnant or planning to become pregnant
- body mass index less than \<18.5 or \>30 kg/m2
- allergy to materials used during the experiment.(e.g. latex),
- known allergy to study drugs
Key Trial Info
Start Date :
December 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2024
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06157580
Start Date
December 8 2023
End Date
December 10 2024
Last Update
December 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa
Iowa City, Iowa, United States, 52242